MLV & Co Has Positive Outlook On Galectin Therapeutics Inc By: Benzinga via Benzinga September 16, 2014 at 09:56 AM EDT In a report published Tuesday, MLV & Co analyst Vernon T. Bernardino reiterated a Buy rating and $16.00 price target on Galectin ... Read More >> Related Stocks: Galectin Therapeutic